EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 14 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,578,749 | +3.9% | 248,674 | 0.0% | 1.28% | +38.9% |
Q4 2022 | $2,481,767 | -0.4% | 248,674 | 0.0% | 0.92% | +15.9% |
Q3 2022 | $2,492,000 | 0.0% | 248,674 | 0.0% | 0.79% | -15.4% |
Q2 2022 | $2,492,000 | +1.6% | 248,674 | 0.0% | 0.94% | +15.4% |
Q1 2022 | $2,452,000 | -1.2% | 248,674 | 0.0% | 0.81% | +8.4% |
Q4 2021 | $2,482,000 | +0.3% | 248,674 | 0.0% | 0.75% | -5.2% |
Q3 2021 | $2,474,000 | -19.2% | 248,674 | -17.1% | 0.79% | +3.7% |
Q2 2021 | $3,060,000 | +1.9% | 300,000 | 0.0% | 0.76% | +24.8% |
Q1 2021 | $3,004,000 | -6.1% | 300,000 | 0.0% | 0.61% | -6.9% |
Q4 2020 | $3,198,000 | – | 300,000 | – | 0.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|